• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC NAVISTAR RMT THERMOCOOL; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC NAVISTAR RMT THERMOCOOL; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Catalog Number NR7TCSIY
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 05/13/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device investigation details: an analysis of the product could not be performed since a physical sample was not received for evaluation.However, if the product is received at a later date, the investigation will be updated as applicable.A manufacturing record evaluation was performed for the finished device number lot: 31311278m and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.#: (b)(4).
 
Event or Problem Description
It was reported that a patient underwent a cardiac ablation procedure with a navistar rmt thermocool and the patient experienced cardiac tamponade that required drainage.Cardiac tamponade was confirmed after the procedure and drainage was performed.About 500 ml was drawn with drainage.Patient did not require prolonged hospitalization.There were no abnormalities prior to or during use of the product.Relevant past medical history include subcutaneous implantable cardioverter-defibrillator (s-icd) had been implanted due to brugada syndrome.Reported laboratory test and results include coronary angiography (cag).Since epi ablation was performed, the physician checked for any effects due to the ablation with the coronary angiogram, however, no abnormalities were found.Patient fully recovered.It was reported that procedural activated clotting time (act) 128 seconds then 163 seconds then 163 seconds then 125 seconds and then 98 seconds.No transseptal puncture was performed.No evidence of steam pop.The flow setting was 10 ml because of epi case.There were no error messages observed on biosense webster equipment during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVISTAR RMT THERMOCOOL
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key22148586
Report Number2029046-2025-01827
Device Sequence Number8308736
Product Code OAD
UDI-Device Identifier10846835008500
UDI-Public(01)10846835008500(17)270424(10)31311278M
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P030031
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberNR7TCSIY
Device Lot Number31311278M
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/13/2025
Initial Report FDA Received Date06/05/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/25/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Life Threatening;
Patient Age33 YR
Patient SexMale
Patient Weight62 KG
Patient EthnicityNon Hispanic
Patient RaceAsian
-
-